uniQure (QURE) Gains from Investment Securities (2023 - 2026)
uniQure's (QURE) quarterly Gains from Investment Securities came in at -$3.8 million in Q1 2026, down 409.95% year-on-year from $1.2 million in Q1 2025, and down 817.9% quarter-over-quarter from $525000.0 in Q4 2025.
uniQure (QURE) Gains from Investment Securities (2023 - 2026) Analysis & Trends
uniQure's Gains from Investment Securities history runs 4 years deep, the most recent figure standing at -$3.8 million for Q1 2026.
- On a quarterly basis, Gains from Investment Securities fell 409.95% year-over-year to -$3.8 million in Q1 2026; TTM through Mar 2026 was $4.7 million, a 714.88% increase from a year earlier, with the FY2025 full-year figure at $6.2 million, up 443.81% from the prior year.
- Gains from Investment Securities slipped to -$3.8 million in Q1 2026 per QURE's latest filing, from $525000.0 in the prior quarter.
- Across five years, Gains from Investment Securities topped out at $14.2 million in Q3 2023 and bottomed at -$3.8 million in Q1 2026.
- The 4-year median for Gains from Investment Securities is $454000.0 (2023), against an average of $1.5 million.
- Across the five-year window, Gains from Investment Securities tumbled 853.59% in 2024 and jumped 1486.86% in 2025, its largest moves.
- Year by year, Gains from Investment Securities stood at $454000.0 in 2023, then tumbled by 52.64% to $215000.0 in 2024, then jumped by 144.19% to $525000.0 in 2025, then tumbled by 817.9% to -$3.8 million in 2026.
- Per Business Quant, the three latest QURE Gains from Investment Securities figures stand at -$3.8 million (Q1 2026), $525000.0 (Q4 2025), and $5.7 million (Q3 2025).
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Oculis Holding AG | 66,621.14 Bn | 66,620.85 Bn | - |
| 2 | Nanobiotix | 1,915.18 Bn | 1,915.11 Bn | - |
| 3 | Akari Therapeutics | 1,014.18 Bn | 1,014.18 Bn | - |
| 4 | BeOne Medicines | 471.27 Bn | 466.48 Bn | 1.35 Bn |
| 5 | Vertex Pharmaceuticals | 121.81 Bn | 114.57 Bn | 2.59 Bn |
| 6 | Regeneron Pharmaceuticals | 69.58 Bn | 60.82 Bn | 3.31 Bn |
| 7 | Belite Bio | 62.72 Bn | 62.72 Bn | - |
| 8 | Argenx Se | 55.51 Bn | 50.33 Bn | 1.41 Bn |
| 9 | Revolution Medicines | 37.35 Bn | 37.35 Bn | - |
| 10 | uniQure | 2.41 Bn | 2.41 Bn | 3.34 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -3.77 Mn |
| Mar 31, 2026 | -3.77 Mn |
| Dec 31, 2025 | 525,000.00 |
| Dec 31, 2025 | 525,000.00 |
| Sep 30, 2025 | 5.70 Mn |
| Sep 30, 2025 | 5.70 Mn |
| Jun 30, 2025 | 2.25 Mn |
| Jun 30, 2025 | 2.25 Mn |
| Mar 31, 2025 | 1.22 Mn |
| Mar 31, 2025 | 1.22 Mn |
| Dec 31, 2024 | 215,000.00 |
| Dec 31, 2024 | 215,000.00 |
| Sep 30, 2024 | -411,000.00 |
| Sep 30, 2024 | -411,000.00 |
| Jun 30, 2024 | -1.79 Mn |
| Jun 30, 2024 | -1.79 Mn |
| Mar 31, 2024 | 165,000.00 |
| Mar 31, 2024 | 165,000.00 |
| Dec 31, 2023 | 454,000.00 |
| Dec 31, 2023 | 454,000.00 |